Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

E.H. Vogelzang; E.L. Kneepkens; M.T. Nurmohamed; A.W.R. van Kuijk; T. Rispens; G. Wolbink; C.L.M. Krieckaert

doi:10.1136/annrheumdis-2014-205554

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

E.H. Vogelzang, E.L. Kneepkens, M.T. Nurmohamed, A.W.R. van Kuijk, T. Rispens, G. Wolbink, C.L.M. Krieckaert

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2178-2182
Journal	Annals of the Rheumatic Diseases
Volume	73
Issue number	12
DOIs	https://doi.org/10.1136/annrheumdis-2014-205554
Publication status	Published - 2014

Access to Document

10.1136/annrheumdis-2014-205554

Cite this

Vogelzang, E. H., Kneepkens, E. L., Nurmohamed, M. T., van Kuijk, A. W. R., Rispens, T., Wolbink, G., & Krieckaert, C. L. M. (2014). Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up. Annals of the Rheumatic Diseases, 73(12), 2178-2182. https://doi.org/10.1136/annrheumdis-2014-205554

@article{0b0c6fd0c35d45b791ea7fe63c0d8583,

title = "Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up",

author = "E.H. Vogelzang and E.L. Kneepkens and M.T. Nurmohamed and {van Kuijk}, A.W.R. and T. Rispens and G. Wolbink and C.L.M. Krieckaert",

year = "2014",

doi = "10.1136/annrheumdis-2014-205554",

language = "Undefined/Unknown",

volume = "73",

pages = "2178--2182",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "12",

}

Vogelzang, EH, Kneepkens, EL, Nurmohamed, MT, van Kuijk, AWR, Rispens, T, Wolbink, G & Krieckaert, CLM 2014, 'Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up', Annals of the Rheumatic Diseases, vol. 73, no. 12, pp. 2178-2182. https://doi.org/10.1136/annrheumdis-2014-205554

TY - JOUR

T1 - Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

AU - Vogelzang, E.H.

AU - Kneepkens, E.L.

AU - Nurmohamed, M.T.

AU - van Kuijk, A.W.R.

AU - Rispens, T.

AU - Wolbink, G.

AU - Krieckaert, C.L.M.

PY - 2014

Y1 - 2014

U2 - 10.1136/annrheumdis-2014-205554

DO - 10.1136/annrheumdis-2014-205554

M3 - Article

C2 - 25115447

SN - 0003-4967

VL - 73

SP - 2178

EP - 2182

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 12

ER -